Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

RAPT Therapeutics (RAPT) EBT Margin: 2020-2022

Historic EBT Margin for Therapeutics (RAPT) over the last 2 years, with Jun 2022 value amounting to -2,134.20%.

  • Therapeutics' EBT Margin fell 28034.00% to -2,134.20% in Q2 2022 from the same period last year, while for Jun 2022 it was -2,347.37%, marking a year-over-year decrease of 113818.00%. This contributed to the annual value of -5,618.53% for FY2022, which is 380358.00% down from last year.
  • According to the latest figures from Q2 2022, Therapeutics' EBT Margin is -2,134.20%, which was up 34.16% from -3,241.34% recorded in Q1 2022.
  • Over the past 5 years, Therapeutics' EBT Margin peaked at -938.74% during Q3 2020, and registered a low of -3,241.34% during Q1 2022.
  • Over the past 3 years, Therapeutics' median EBT Margin value was -1,616.87% (recorded in 2020), while the average stood at -1,711.37%.
  • Its EBT Margin has fluctuated over the past 5 years, first soared by 2,850bps in 2021, then crashed by 188,995bps in 2022.
  • Quarterly analysis of 3 years shows Therapeutics' EBT Margin stood at -962.83% in 2020, then slumped by 140,873bps to -2,371.56% in 2021, then plummeted by 28,034bps to -2,134.20% in 2022.
  • Its EBT Margin stands at -2,134.20% for Q2 2022, versus -3,241.34% for Q1 2022 and -2,371.56% for Q4 2021.